Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-01
2000-01-25
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31335
Patent
active
06017949&
ABSTRACT:
A method of inhibiting angiogenesis in a female mammal to regulate fertility comprising administering to the female mammal an effective amount of an angiogenesis inhibiting compound. In addition, a method of inhibiting angiogenesis in a female mammal to treat a disease or condition of the reproductive tissue that is mediated by angiogenesis comprising administering to the female mammal an effective amount of an angiogenesis inhibiting compound. AGM-1470 is provided as such an angiogenesis inhibiting compound.
REFERENCES:
patent: 4599331 (1986-07-01), Schreiber
Klauber, N. et al., "Critical Components of the Female Reproductive Pathway are Suppressed by the Angiogenesis Inhibitor AGM-1470", Nature Medicine, vol. 3, No. 4, pp. 443-446 (1997).
Abe, J. et al., A Fumagillin Derivative Angiogenesis Inhibitor, AGM-1470, Inhibits Activation of Cyclin-Dependent Kinases and Phosphorylation of Retinoblastoma Gene Product but not Protein Tyrosyl Phosphorylation of Protooncogene Expression in Vascular Endothelial Cells, Cancer Research, vol. 54, No. 13, pp. 3407-3412 (1994).
Brem, H. et al., "Interstitial Chemotherapy with Drug Polymer Implants for the Treatment of Recurrent Gliomas", Journal of Neurosurgery, vol. 74, pp. 441-46 (1991).
Champlin, A.K. et al., "Determining the Stage of the Estrous Cycle in the Mouse by the Appearance of the Vagina", Biology of Reproduction, vol. 8, pp. 491-494 (1973).
Christenson, L.K. et al., "Proliferation of Microvascular Endothelial Cells in the Primate Corpus Luteum during the Menstrual Cycle and Simulated Early Pregancy", Endocrinology, vol. 137, No. 1, pp. 367-374 (1996).
Christofferson, R. H. et al., "Morphology of the Endometrial Microvasculature During Early Placentation in the Rat", Cell and Tissue Research, vol. 253, No. 1, pp. 209-220 (1988).
Connolly, D. T. et al., "Human Vascular Permeability Factor", The Journal of Bilogical Chemistry, vol. 264, No. 23, pp. 20017-20024 (1989).
D'Amato, R.J. et al., "Thalidomide is an Inhibitor of Angiogenesis", Proceedings of National Academy of Sciences, vol. 91, pp. 4082-4085 (1994).
Ferrara, N. et al., "Pituitary Follicular Cells Secrete a Novel Heparin-Binding Growth Factor Specific for Vascular Endothelial Cells", Biochemical and Biophysical Research Commuications, vol. 161, pp. 851-858 (1989).
Folkman, J. et al., "Angiogenic Factors", Science, vol. 235, pp. 442-447 (1987).
Goodger, A.M. et al., "Uterine Endothelial Proliferation Before and After Embryo Implantation", Journal Reproduction Fertility, vol. 99, pp. 451-457 (1993).
Gospodarowicz, D. et al., "Isolation and Characterization of a Vascular Endothelial Mitogen Produced by Pituitary-Derived Folliculo Stellate Cells", Proceedings of the National Academy of Sciences, vol. 86, pp. 7311-7315 (1989).
Gospodarowicz, D. et al., "Production of a Corpus Luteum Angiogenic Factor Responsible for the Proliferation of Capillaries and Neovascularization of the Corpus Lutem", Proceedings of the National Academy of Sciences, vol. 75, pp. 847-851 (1978).
Greenwald, G.S., "Temporal and Topographic Changes in DNA Synthesis after Follicular Atresia", Biology o Reproduction, vol. 41 (1), pp. 175-181 (1989).
Jakob, W. et al., "Demonstration of Angiogenesis Activiity in the Corpus Luteum of Cattle", Experimental Pathology, vol. 13, pp. 231-236 (1977).
Kamat, B.R. et al., "Expression of Vascular Permeability Factor/Vascular Endothelial Growth Factor by Human Granulosa and Theca Lutein Cells", American Journal o Pathology, vol. 146, pp. 157-165 (1995).
Keck, P.J. et al., "Cascular Permeability Factor, an Endothelial Cell Mitogen Related o PDGF", Science, vol. 246, pp. 1309-1312 (1989).
Koos, R.D. et al., "Expression of Basic Fibroblast Growth Factor in the Rat Ovary: Detection of mRNA using Reverse Transcription-Polymerase Chain Amplification", Molecular Endocrinology, vol. 3, No. 12, pp. 2041-2048 (1989).
Koos, R.D. et al., "Factors that May Regulate the Growth and Regression of Blood Vessels in the Ovary", Seminars in Reproductive Endocrinology, vol. 1, pp. 295-307 (1983).
Neufeld, G. et al., "Bovine Granulosa Cells Produce Basic Fibroblast Growth Factor", Endocrinology, vol. 121, pp. 597-603 (1987).
Poole, T.J. et al., "Vasculogenesis and Angiogenesis: Two Distinct Morphogenetic Mechanisms Establish Embryonic Pattern", Journal of Experimental Zoology, vol. 251, pp. 224-231 (1989).
Tsukada et al. "Neovascularization of the Corpus Luteum of Rats During the Estrus Cycle", Pathology International, vol. 46 (6), pp. 408-416 (1996).
Ravindranath, N. et al., "Vascular Endothelial Growth Factor Messenger Ribonucleic Acid Expression in the Primate Ovary", Endocrinology, vol. 131, pp. 254-260 (1992).
Redmer, D.A. et al., "Evidence for a Non-Steroidal Angiotropic Factor from the Primate Corpus Luteum: Stimulation of Endothelial Cell Migration in Vitro", Proceedings of the Society for Expermental Biology and Medicine, vol. 179, pp. 136-140 (1985).
Schlaeger, T.M. et al., "Vascular Endothelial Cell Lineage-Specific Promoter in Transgenic Mice", Development, vol. 121, pp. 1089-1098 (1995).
Shweiki, D. et al., "Patterns of Expression of Vascular Endothelial Growth Factor and VEFG Receptors in Mice Suggest a Role in Hormonally Regulated Angiogenesis", Journal of Clinical Investigation, vol. 91, pp. 2235-2243 (1995).
Tamura, H. et al., "Angiogenesis and Its Hormonal Control in the Corpus Luteum of the Pregnant Rat", Biology of Reproduction, vol. 36, pp. 1149-1154 (1987).
Torry, R. et al., "Angiogenesis in the Uterus: Potential Regulation and Relation to Tumor Angiogenesis", American Journal of Reproductive Immunology, vol. 27, pp. 171-179 (1992).
Yanagashita, M. et al., "Biosynthesis of Proteoglycans by Rat Granulosa Cells Cultured In Vitro: Modulation by Gonadotropins, Steroid Hormones, Protaglandins and Cyclic Nucleotide", Endocrinology, vol. 109, pp. 1641-1649 (1981).
Zeleznik, A.J. et al., "Gonadotropin-Binding Sites in the Rhesus Monkey Ovary: Role of the Vasculature in the Selective Distribution of Human Chorionic Gonadotropin to the Preovulatory Follicle", Endrocinology, vol. 109, pp. 356-362 (1981).
Merck Manual 16th ed, pp. 1808-1809 Beichow et al Ed, Merck & Co Rahway NJ, 1992.
Ingker et al, Nature, vol. 348, pp. 555-557 Dec, 6, 1990.
Toguebage et al 99 CA:83611t, 1983.
D'Amato Robert J.
Demore Nancy Klauber
LandOfFree
Method of regulating the female reproductive system through angi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of regulating the female reproductive system through angi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of regulating the female reproductive system through angi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316285